CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.

CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Me...

Descripción completa

Detalles Bibliográficos
Autores: Cañada García, Javier E., Moure, Zaira, Sola Campoy, Pedro J., Delgado Valverde, Mercedes, Cano, María E., Gijón Cordero, Desirée, González, Mónica, Gracia Ahufinger, Irene, Larrosa, Nieves, Mulet, Xavier, Pitart, Cristina, Rivera, Alba, Bou, Germán, Calvo, Jorge, Cantón, Rafael, González-López, Juan José, Martínez-Martínez, Luis, Navarro, Ferran, Oliver, Antonio, Palacios Baena, Zaira R., Pascual, Alvaro, Ruiz Carrascoso, Guillermo, Vila Estapé, Jordi, Aracil, Belén, Pérez-Vázquez, María, Oteo Iglesias, Jesús, GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/191256
Acceso en línea:https://hdl.handle.net/2445/191256
Access Level:acceso abierto
Palabra clave:Antibiòtics betalactàmics
Klebsiella pneumoniae
Escheríchia coli
Genoma humà
Enterobacteriàcies
Beta lactam antibiotics
Escherichia coli
Human genome
Enterobacteriaceae
id ES_f2cedb33b27945f95c27f9c3d99ce47e
oai_identifier_str oai:diposit.ub.edu:2445/191256
network_acronym_str ES
network_name_str España
repository_id_str
spelling CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.Cañada García, Javier E.Moure, ZairaSola Campoy, Pedro J.Delgado Valverde, MercedesCano, María E.Gijón Cordero, DesiréeGonzález, MónicaGracia Ahufinger, IreneLarrosa, NievesMulet, XavierPitart, CristinaRivera, AlbaBou, GermánCalvo, JorgeCantón, RafaelGonzález-López, Juan JoséMartínez-Martínez, LuisNavarro, FerranOliver, AntonioPalacios Baena, Zaira R.Pascual, AlvaroRuiz Carrascoso, GuillermoVila Estapé, JordiAracil, BelénPérez-Vázquez, MaríaOteo Iglesias, JesúsGEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study GroupAntibiòtics betalactàmicsKlebsiella pneumoniaeEscheríchia coliGenoma humàEnterobacteriàciesBeta lactam antibioticsKlebsiella pneumoniaeEscherichia coliHuman genomeEnterobacteriaceaeCARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3.Frontiers Media2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/191256Articles publicats en revistes (Fonaments Clínics)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.3389/fmicb.2022.918362Frontiers in Microbiology, 2022, vol. 13, p. 918362https://doi.org/10.3389/fmicb.2022.918362cc-by (c) Cañada García, Javier E. et al., 2022https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1912562026-05-27T06:46:51Z
dc.title.none.fl_str_mv CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
title CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
spellingShingle CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
Cañada García, Javier E.
Antibiòtics betalactàmics
Klebsiella pneumoniae
Escheríchia coli
Genoma humà
Enterobacteriàcies
Beta lactam antibiotics
Klebsiella pneumoniae
Escherichia coli
Human genome
Enterobacteriaceae
title_short CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
title_full CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
title_fullStr CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
title_full_unstemmed CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
title_sort CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
dc.creator.none.fl_str_mv Cañada García, Javier E.
Moure, Zaira
Sola Campoy, Pedro J.
Delgado Valverde, Mercedes
Cano, María E.
Gijón Cordero, Desirée
González, Mónica
Gracia Ahufinger, Irene
Larrosa, Nieves
Mulet, Xavier
Pitart, Cristina
Rivera, Alba
Bou, Germán
Calvo, Jorge
Cantón, Rafael
González-López, Juan José
Martínez-Martínez, Luis
Navarro, Ferran
Oliver, Antonio
Palacios Baena, Zaira R.
Pascual, Alvaro
Ruiz Carrascoso, Guillermo
Vila Estapé, Jordi
Aracil, Belén
Pérez-Vázquez, María
Oteo Iglesias, Jesús
GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group
author Cañada García, Javier E.
author_facet Cañada García, Javier E.
Moure, Zaira
Sola Campoy, Pedro J.
Delgado Valverde, Mercedes
Cano, María E.
Gijón Cordero, Desirée
González, Mónica
Gracia Ahufinger, Irene
Larrosa, Nieves
Mulet, Xavier
Pitart, Cristina
Rivera, Alba
Bou, Germán
Calvo, Jorge
Cantón, Rafael
González-López, Juan José
Martínez-Martínez, Luis
Navarro, Ferran
Oliver, Antonio
Palacios Baena, Zaira R.
Pascual, Alvaro
Ruiz Carrascoso, Guillermo
Vila Estapé, Jordi
Aracil, Belén
Pérez-Vázquez, María
Oteo Iglesias, Jesús
GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group
author_role author
author2 Moure, Zaira
Sola Campoy, Pedro J.
Delgado Valverde, Mercedes
Cano, María E.
Gijón Cordero, Desirée
González, Mónica
Gracia Ahufinger, Irene
Larrosa, Nieves
Mulet, Xavier
Pitart, Cristina
Rivera, Alba
Bou, Germán
Calvo, Jorge
Cantón, Rafael
González-López, Juan José
Martínez-Martínez, Luis
Navarro, Ferran
Oliver, Antonio
Palacios Baena, Zaira R.
Pascual, Alvaro
Ruiz Carrascoso, Guillermo
Vila Estapé, Jordi
Aracil, Belén
Pérez-Vázquez, María
Oteo Iglesias, Jesús
GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Antibiòtics betalactàmics
Klebsiella pneumoniae
Escheríchia coli
Genoma humà
Enterobacteriàcies
Beta lactam antibiotics
Klebsiella pneumoniae
Escherichia coli
Human genome
Enterobacteriaceae
topic Antibiòtics betalactàmics
Klebsiella pneumoniae
Escheríchia coli
Genoma humà
Enterobacteriàcies
Beta lactam antibiotics
Klebsiella pneumoniae
Escherichia coli
Human genome
Enterobacteriaceae
description CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3.
publishDate 2022
dc.date.none.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/191256
url https://hdl.handle.net/2445/191256
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.3389/fmicb.2022.918362
Frontiers in Microbiology, 2022, vol. 13, p. 918362
https://doi.org/10.3389/fmicb.2022.918362
dc.rights.none.fl_str_mv cc-by (c) Cañada García, Javier E. et al., 2022
https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Cañada García, Javier E. et al., 2022
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv Articles publicats en revistes (Fonaments Clínics)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869424316802662400
score 15,300719